yes, the ARDS market is huge. However, had NVS been enticed by revenue from Covid EUA they may have given the green light to invest in further ARDS trials. Remember, they were offering a large royalty for the covid EUA, so it must have been a significant enough ROI if the EUA was granted. No EUA makes the ARDS trials more expensive in that regard. Claiming anything happening in the OTAT assessment has anything to do with ARDS is wrong.
yes, the ARDS market is huge. However, had NVS been enticed by...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |